Comparison Of Characteristics Of Patients Diagnosed With Relapsing Remitting Multiple Sclerosis And Taking Subcutaneously Administered Disease Modifying Therapies- Interferon Beta 1b Versus 1a
Abstract
Authors
M Greene N Greene